Correlation Between ConforMIS and Evogene
Can any of the company-specific risk be diversified away by investing in both ConforMIS and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ConforMIS and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ConforMIS and Evogene, you can compare the effects of market volatilities on ConforMIS and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ConforMIS with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of ConforMIS and Evogene.
Diversification Opportunities for ConforMIS and Evogene
Pay attention - limited upside
The 3 months correlation between ConforMIS and Evogene is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding ConforMIS and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and ConforMIS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ConforMIS are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of ConforMIS i.e., ConforMIS and Evogene go up and down completely randomly.
Pair Corralation between ConforMIS and Evogene
If you would invest 223.00 in ConforMIS on September 14, 2024 and sell it today you would earn a total of 0.00 from holding ConforMIS or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
ConforMIS vs. Evogene
Performance |
Timeline |
ConforMIS |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Evogene |
ConforMIS and Evogene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ConforMIS and Evogene
The main advantage of trading using opposite ConforMIS and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ConforMIS position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.ConforMIS vs. Bone Biologics Corp | ConforMIS vs. Tivic Health Systems | ConforMIS vs. Bluejay Diagnostics | ConforMIS vs. Vivos Therapeutics |
Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |